PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
22.25%
Revenue growth above 1.5x MRVL's 3.14%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
30.11%
Gross profit growth above 1.5x MRVL's 6.07%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
114.75%
EBIT growth 1.25-1.5x MRVL's 93.79%. Bruce Berkowitz would verify if strategic initiatives are driving this edge.
114.75%
Operating income growth 1.25-1.5x MRVL's 93.79%. Bruce Berkowitz would see if strategic measures (e.g., cost cutting, product mix) are succeeding.
114.79%
Net income growth 1.25-1.5x MRVL's 85.49%. Bruce Berkowitz would see if strategic cost cutting or product mix explains this difference.
116.00%
EPS growth 1.25-1.5x MRVL's 85.75%. Bruce Berkowitz would check if strategic initiatives like cost cutting or better capital management explain the difference.
112.00%
Diluted EPS growth 1.25-1.5x MRVL's 85.75%. Bruce Berkowitz would verify if strategic moves (e.g., targeted acquisitions, cost cuts) explain the edge.
0.32%
Share reduction more than 1.5x MRVL's 1.92%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.64%
Diluted share count expanding well above MRVL's 0.44%. Michael Burry would fear significant dilution to existing owners' stakes.
-0.32%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-18.38%
Negative OCF growth while MRVL is at 14.04%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-40.30%
Negative FCF growth while MRVL is at 7.43%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
423.15%
Positive 10Y revenue/share CAGR while MRVL is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
217.61%
Positive 5Y CAGR while MRVL is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
74.94%
Positive 3Y CAGR while MRVL is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
463.12%
Positive long-term OCF/share growth while MRVL is negative. John Neff would see a structural advantage in sustained cash generation.
339.89%
5Y OCF/share CAGR above 1.5x MRVL's 191.18%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
7.86%
Positive 3Y OCF/share CAGR while MRVL is negative. John Neff might see a big short-term edge in operational efficiency.
1370.70%
Positive 10Y CAGR while MRVL is negative. John Neff might see a substantial advantage in bottom-line trajectory.
376.30%
5Y net income/share CAGR above 1.5x MRVL's 72.06%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
55.56%
Positive short-term CAGR while MRVL is negative. John Neff would see a clear advantage in near-term profit trajectory.
394.32%
10Y equity/share CAGR above 1.5x MRVL's 55.52%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
201.19%
5Y equity/share CAGR above 1.5x MRVL's 53.64%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
135.54%
3Y equity/share CAGR above 1.5x MRVL's 52.24%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
63.82%
5Y dividend/share CAGR above 1.5x MRVL's 0.07%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
15.00%
3Y dividend/share CAGR above 1.5x MRVL's 0.60%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
22.17%
AR growth well above MRVL's 1.39%. Michael Burry fears inflated revenue or higher default risk in the near future.
6.71%
Inventory growth well above MRVL's 2.10%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
6.76%
Positive asset growth while MRVL is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
9.85%
Positive BV/share change while MRVL is negative. John Neff sees a clear edge over a competitor losing equity.
-1.69%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
5.02%
We increase R&D while MRVL cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
-17.86%
We cut SG&A while MRVL invests at 2.40%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.